Clinical-stage biopharmaceutical company ShouTi Inc has mopped up as much as $100 million in its Series B round of financing led by BVF Partners, a San Francisco-based private investment firm.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
